1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Liquid Filtration for Pharmaceutical Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Liquid Filtration for Pharmaceutical Market, by Filtration Type
8.1.1. Membrane Filtration
8.1.1.1. Market Revenue and Forecast
8.1.2. Depth Filtration
8.1.2.1. Market Revenue and Forecast
8.1.3. Sterile Filtration
8.1.3.1. Market Revenue and Forecast
8.1.4. Others
8.1.4.1. Market Revenue and Forecast
9.1. Liquid Filtration for Pharmaceutical Market, by Filtration Material
9.1.1. Polyethersulfone (PES)
9.1.1.1. Market Revenue and Forecast
9.1.2. Polyvinylidene Fluoride (PVDF)
9.1.2.1. Market Revenue and Forecast
9.1.3. Cellulose Acetate
9.1.3.1. Market Revenue and Forecast
9.1.4. Nylon
9.1.4.1. Market Revenue and Forecast
9.1.5. Polypropylene
9.1.5.1. Market Revenue and Forecast
9.1.6. Stainless Steel
9.1.6.1. Market Revenue and Forecast
9.1.7. Others
9.1.7.1. Market Revenue and Forecast
10.1. Liquid Filtration for Pharmaceutical Market, by Application / Use Case
10.1.1. Biopharmaceutical Production
10.1.1.1. Market Revenue and Forecast
10.1.2. Vaccine Manufacturing
10.1.2.1. Market Revenue and Forecast
10.1.3. Injectable Drugs
10.1.3.1. Market Revenue and Forecast
10.1.4. Bulk Drug Intermediates
10.1.4.1. Market Revenue and Forecast
10.1.5. Research & Laboratory Use
10.1.5.1. Market Revenue and Forecast
11.1. Liquid Filtration for Pharmaceutical Market, by End User
11.1.1. Pharmaceutical Manufacturers
11.1.1.1. Market Revenue and Forecast
11.1.2. Biopharmaceutical Companies
11.1.2.1. Market Revenue and Forecast
11.1.3. Contract Manufacturing Organizations (CMOs)
11.1.3.1. Market Revenue and Forecast
11.1.4. Research & Academic Institutes
11.1.4.1. Market Revenue and Forecast
11.1.5. Others
11.1.5.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Filtration Type
12.1.2. Market Revenue and Forecast, by Filtration Material
12.1.3. Market Revenue and Forecast, by Application / Use Case
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Filtration Type
12.1.5.2. Market Revenue and Forecast, by Filtration Material
12.1.5.3. Market Revenue and Forecast, by Application / Use Case
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Filtration Type
12.1.6.2. Market Revenue and Forecast, by Filtration Material
12.1.6.3. Market Revenue and Forecast, by Application / Use Case
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Filtration Type
12.2.2. Market Revenue and Forecast, by Filtration Material
12.2.3. Market Revenue and Forecast, by Application / Use Case
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Filtration Type
12.2.5.2. Market Revenue and Forecast, by Filtration Material
12.2.5.3. Market Revenue and Forecast, by Application / Use Case
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Filtration Type
12.2.6.2. Market Revenue and Forecast, by Filtration Material
12.2.6.3. Market Revenue and Forecast, by Application / Use Case
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Filtration Type
12.2.7.2. Market Revenue and Forecast, by Filtration Material
12.2.7.3. Market Revenue and Forecast, by Application / Use Case
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Filtration Type
12.2.8.2. Market Revenue and Forecast, by Filtration Material
12.2.8.3. Market Revenue and Forecast, by Application / Use Case
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Filtration Type
12.3.2. Market Revenue and Forecast, by Filtration Material
12.3.3. Market Revenue and Forecast, by Application / Use Case
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Filtration Type
12.3.5.2. Market Revenue and Forecast, by Filtration Material
12.3.5.3. Market Revenue and Forecast, by Application / Use Case
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Filtration Type
12.3.6.2. Market Revenue and Forecast, by Filtration Material
12.3.6.3. Market Revenue and Forecast, by Application / Use Case
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Filtration Type
12.3.7.2. Market Revenue and Forecast, by Filtration Material
12.3.7.3. Market Revenue and Forecast, by Application / Use Case
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Filtration Type
12.3.8.2. Market Revenue and Forecast, by Filtration Material
12.3.8.3. Market Revenue and Forecast, by Application / Use Case
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Filtration Type
12.4.2. Market Revenue and Forecast, by Filtration Material
12.4.3. Market Revenue and Forecast, by Application / Use Case
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Filtration Type
12.4.5.2. Market Revenue and Forecast, by Filtration Material
12.4.5.3. Market Revenue and Forecast, by Application / Use Case
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Filtration Type
12.4.6.2. Market Revenue and Forecast, by Filtration Material
12.4.6.3. Market Revenue and Forecast, by Application / Use Case
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Filtration Type
12.4.7.2. Market Revenue and Forecast, by Filtration Material
12.4.7.3. Market Revenue and Forecast, by Application / Use Case
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Filtration Type
12.4.8.2. Market Revenue and Forecast, by Filtration Material
12.4.8.3. Market Revenue and Forecast, by Application / Use Case
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Filtration Type
12.5.2. Market Revenue and Forecast, by Filtration Material
12.5.3. Market Revenue and Forecast, by Application / Use Case
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Filtration Type
12.5.5.2. Market Revenue and Forecast, by Filtration Material
12.5.5.3. Market Revenue and Forecast, by Application / Use Case
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Filtration Type
12.5.6.2. Market Revenue and Forecast, by Filtration Material
12.5.6.3. Market Revenue and Forecast, by Application / Use Case
12.5.6.4. Market Revenue and Forecast, by End User
13.1. Parker Hannifin Corporation
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Eaton Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. GE Healthcare Life Sciences
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Filtration Group Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Thermo Fisher Scientific
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Advantec MFS, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Ahlstrom-Munksjö
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Meissner Filtration Products
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Nitto Denko Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Toray Industries, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
